112 related articles for article (PubMed ID: 8723531)
1. Elevated local production of neopterin from alveolar macrophages in patients with internal lung diseases.
Saito M; Chihara J; Mouri T; Kurachi D; Yamamoto T; Nakajima S
Gen Pharmacol; 1996 Apr; 27(3):483-6. PubMed ID: 8723531
[TBL] [Abstract][Full Text] [Related]
2. Unconjugated pteridines in bronchoalveolar lavage as indicators of alveolar macrophage activation.
Dhondt JL; Darras A; Mulliez P; Hayte JM; Crinquette J
Chest; 1989 Feb; 95(2):348-51. PubMed ID: 2914487
[TBL] [Abstract][Full Text] [Related]
3. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory effects of recombinant interleukin-3 treatment on human alveolar macrophages and monocytes.
Thomassen MJ; Antal JM; Connors MJ; McLain D; Sandstrom K; Meeker DP; Budd GT; Levitt D; Bukowski RM
J Immunother Emphasis Tumor Immunol; 1993 Jul; 14(1):43-50. PubMed ID: 8399069
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary sarcoidosis: patterns of cytokine release in vitro.
Prior C; Knight RA; Herold M; Ott G; Spiteri MA
Eur Respir J; 1996 Jan; 9(1):47-53. PubMed ID: 8834333
[TBL] [Abstract][Full Text] [Related]
6. Relative release of interleukin-1 beta and interleukin-1 receptor antagonist by alveolar macrophages. A study in asbestos-induced lung disease, sarcoidosis, and idiopathic pulmonary fibrosis.
Kline JN; Schwartz DA; Monick MM; Floerchinger CS; Hunninghake GW
Chest; 1993 Jul; 104(1):47-53. PubMed ID: 8325116
[TBL] [Abstract][Full Text] [Related]
7. Urinary neopterin in pulmonary sarcoidosis. Relationship to clinical and biologic assessment of the disease.
Lacronique J; Auzeby A; Valeyre D; Traore BM; Barbosa ML; Soler P; Choudat D; Battesti JP; Touitou Y; Marsac J
Am Rev Respir Dis; 1989 Jun; 139(6):1474-8. PubMed ID: 2543248
[TBL] [Abstract][Full Text] [Related]
8. Enhanced production of IL-1 receptor antagonist by alveolar macrophages from patients with interstitial lung disease.
Janson RW; King TE; Hance KR; Arend WP
Am Rev Respir Dis; 1993 Aug; 148(2):495-503. PubMed ID: 8342915
[TBL] [Abstract][Full Text] [Related]
9. Role of galectin-3 in human pulmonary fibrosis.
Nishi Y; Sano H; Kawashima T; Okada T; Kuroda T; Kikkawa K; Kawashima S; Tanabe M; Goto T; Matsuzawa Y; Matsumura R; Tomioka H; Liu FT; Shirai K
Allergol Int; 2007 Mar; 56(1):57-65. PubMed ID: 17259811
[TBL] [Abstract][Full Text] [Related]
10. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18.
Prasse A; Pechkovsky DV; Toews GB; Jungraithmayr W; Kollert F; Goldmann T; Vollmer E; Müller-Quernheim J; Zissel G
Am J Respir Crit Care Med; 2006 Apr; 173(7):781-92. PubMed ID: 16415274
[TBL] [Abstract][Full Text] [Related]
11. Expression of insulin-like growth factor-I (IGF-I) in alveolar macrophages and lymphocytes obtained by bronchoalveolar lavage (BAL) in interstitial lung diseases (ILD). Assessment of IGF-I as a potential local mitogen and antiapoptotic cytokine.
Kopiński P; Sładek K; Szczeklik J; Soja J; Szlubowski A; Balicka-Slusarczyk B; Lackowska B; Plato M; Szpechciński A
Folia Histochem Cytobiol; 2006; 44(4):249-58. PubMed ID: 17219718
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of soluble CD 14 and neopterin as serum parameters of the inflammatory activity of pulmonary sarcoidosis.
Homolka J; Lorenz J; Zuchold HD; Müller-Quernheim J
Clin Investig; 1992 Oct; 70(10):909-16. PubMed ID: 1280495
[TBL] [Abstract][Full Text] [Related]
13. Neopterin release from human endothelial cells is triggered by interferon-gamma.
Andert SE; Griesmacher A; Zuckermann A; Müller MM
Clin Exp Immunol; 1992 Jun; 88(3):555-8. PubMed ID: 1606740
[TBL] [Abstract][Full Text] [Related]
14. Effects of interferons beta or gamma on neopterin biosynthesis and tryptophan degradation by human alveolar macrophages in vitro: synergy with lipopolysaccharide.
Meyer KC; Cornwell R; Carlin JM; Powers C; Irizarry A; Byrne GI; Borden EC
Am J Respir Cell Mol Biol; 1992 Jun; 6(6):639-46. PubMed ID: 1591013
[TBL] [Abstract][Full Text] [Related]
15. Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction.
Pechkovsky DV; Prasse A; Kollert F; Engel KM; Dentler J; Luttmann W; Friedrich K; Müller-Quernheim J; Zissel G
Clin Immunol; 2010 Oct; 137(1):89-101. PubMed ID: 20674506
[TBL] [Abstract][Full Text] [Related]
16. In vitro modulatory effects of interleukin-3 on macrophage activation induced by interleukin-2.
Lissoni P; Pittalis S; Brivio F; Tisi E; Rovelli F; Ardizzoia A; Barni S; Tancini G; Giudici G; Biondi A
Cancer; 1993 Mar; 71(6):2076-81. PubMed ID: 8443757
[TBL] [Abstract][Full Text] [Related]
17. Quantitative evaluation of the IL-1 beta and IL-1 receptor antagonist obtained from BALF macrophages in patients with interstitial lung diseases.
Mikuniya T; Nagai S; Shimoji T; Takeuchi M; Morita K; Mio T; Satake N; Izumi T
Sarcoidosis Vasc Diffuse Lung Dis; 1997 Mar; 14(1):39-45. PubMed ID: 9186988
[TBL] [Abstract][Full Text] [Related]
18. Alveolar macrophage activation in HIV infection.
Evans MR; Wansbrough-Jones MH
J Infect; 1996 Sep; 33(2):91-4. PubMed ID: 8889995
[TBL] [Abstract][Full Text] [Related]
19. Colony stimulating factors induce alveolar macrophage differentiation and giant cell formation.
Lemaire I; Yang H
Ann N Y Acad Sci; 1996 Oct; 796():173-81. PubMed ID: 8906223
[No Abstract] [Full Text] [Related]
20. Alveolar macrophage surface carbohydrate expression is altered in interstitial lung disease as determined by lectin-binding profiles.
Meyer KC; Powers C; Rosenthal N; Auerbach R
Am Rev Respir Dis; 1993 Nov; 148(5):1325-34. PubMed ID: 8239171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
